Yang Nong, Clinical oncologist
- Specialization: Clinical oncologist
- 31 years of experience
- Speaks:Chinese
- Workplace: China, Qionghai, Boao International Medical Center
- Led nearly 400 clinical trials of novel anticancer drugs.
Chief Physician, Doctoral Supervisor, and Vice President at Hunan Second People’s Hospital. Leader in precision oncology with nearly 30 years of experience. Specializes in pulmonary nodules and early lung cancer. Expert in targeted therapy and immunotherapy. Manages recurrent and drug‑resistant disease and brain metastases. Provides MDT care for gastrointestinal and other solid tumors.
Chief expert for a National Key S&T Project. Council member of CSCO. New drug reviewer for the NMPA. Chair of the Hunan Anti‑Cancer Association Precision Oncology Committee. Director of the provincial lung cancer precision lab and the respiratory oncology center. Led about 400 clinical trials. Co‑drafted national lung cancer guidelines. Published 70 SCI papers in the past five years, including in The Lancet Oncology and JCO. Received five provincial awards and holds three patents. Developed five Class 1.1 drugs. Named a National Renowned Physician. Content viewed over 120 million times.
How are we doing?
Qualifications
Professional Profile:
• Chief Physician, Doctoral Supervisor, Vice President of Hunan Second People’s Hospital, and leader of its oncology discipline.
• Long-term appointed expert at Hainan Cancer Hospital and Hainan Chengmei Hospital.
• Chief expert for a National Key Science and Technology Project and a leading health professional in Hunan Province.
• Head of the Yang Nong Specialist Clinic team, with nearly 30 years of experience in precision cancer diagnosis and treatment.
Clinical Expertise: Specializes in pulmonary nodule assessment, early lung cancer diagnosis, and precision targeted therapy and immunotherapy for lung cancer. · Experienced in complex cases involving recurrent or drug-resistant disease and brain metastases. · Has led nearly 400 clinical trials of novelanticancer drugs. · Also provides individualized multidisciplinary team (MDT) care for gastrointestinal and other solid tumors.
Academic Appointments: Committee Member of the Lung Cancer Committee of the National CancerQuality Control Center and expert in new drug evaluation for China’s National Medical Products Administration (NMPA). · Council Member of the Chinese Society of Clinical Oncology (CSCO) and Chair ofthe Precision Oncology Committee of the Hunan Anti-Cancer Association. · Director of the Hunan Provincial Key Laboratory for Precision Diagnosis and Treatment of Lung Cancer and the Provincial Clinical Medical Research Center for Respiratory Oncology. Associate Editor of Tumor Pharmacy.
Research & Achievements: Contributed to the drafting of several national lung cancer diagnosis and treatment guidelines. · Published 70 SCI-indexed papers over the past five years, including articles in leading journals such as The Lancet Oncology and the Journal of Clinical Oncology (JCO). · Has received five provincial-level research awards, holds three patents, and contributed to the development of five innovative Class 1.1 anticancer drugs. · Recipient of multiple honors, including “National Renowned Physician.” · His public cancer education content has accumulated over 120 million views across online platforms.
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.